deltatrials
Terminated PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00361907

Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes

Effect of Pulsatile IV Insulin Delivery on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes

Sponsor: Advanced Diabetes Treatment Centers

Conditions Diabetes Mellitus
Interventions Effect of Pulsatile IV Insulin on blood markers Effect of Pulsatile IV insulin on diabetic pt blood markers
Updated 5 times since 2017 Last updated: Aug 8, 2016 Started: Feb 28, 2005 Primary completion: Aug 31, 2009 Completion: Aug 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Administrative - Suspended by IRB

Other terminated trials from Advanced Diabetes Treatment Centers

More terminations from Advanced Diabetes Treatment Centers

Other Diabetes Mellitus trials with similar outcome

Browse all Diabetes Mellitus trials

Listed as NCT00361907, this PHASE2/PHASE3 trial focuses on Diabetes Mellitus and remains terminated or withdrawn. Sponsored by Advanced Diabetes Treatment Centers, it has been updated 5 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2_PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2_PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE2_PHASE3

    First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Advanced Diabetes Treatment Centers
  • Florida Atlantic University
Data source: Florida Atlantic University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations